Constellation’s Post

One of the most common things to hear in pharma is that we should work on ‘breaking down silos’. We get it, and we agree with it, but we’re not a lot closer to knowing what we should actually, practically do about it. In my next free #webinar, I will be giving you practical advice on how we can achieve real collaboration between medical and commercial teams. And not just the standard empty phrases. Join me to bust the big questions: why silos exist, why we need to break them down and what we can do about them. Sign up here: https://lnkd.in/egqSScnJ

I am putting together a presentation titled “The Link Between Science & Commercial Strategy for Pre-IPO Pharma Success.” One of the suggested slides is on the topic of best practices early companies engage in to overcome common pitfalls in their pursuit of success. Some of the successful behaviors I listed include - 📈 Understanding how innovation will translate into market success. Great science does not guarantee commercial success.  ⚠️   Factoring the technical risk of FDA approval into strategic planning. Too often, companies      miss key information the FDA is communicating. 🔂 Developing key strategies early based on commercial analytics. Commercial represents a lot more than just sales and marketing.  ⚙️  Having the tools and processes for considering a wide variety of strategic options and risks. All too often companies treat forecasts as number generators vs. strategy assessment tools. Speed to market is rarely a winning strategy. 🗣  Creating dialogue between commercial and clinical leads. A lack of organizational alignment is detrimental to corporate success. Now it’s your turn! Let's start a conversation and learn from each other as we navigate the challenges and opportunities that come with bringing innovative therapies to market. Share your thoughts and experiences in the comments below and let's collaborate for pre-IPO pharma success. #IlluminationStrategyGroup #PharmaInnovation #Teamwork

Veeva Compass...not your grandma's data! I have had the privilege to utilize Compass for the past 2.5 years within our Analytics Consulting practice and it is hands down superior to anything else out there. The Veeva Compass Suite of Patient, Prescriber, and National data is the change we needed in Life Sciences. Come learn more about innovative approaches in data and analytics, meet new connections, and gain insights into how modern commercial data can evolve your business. #Veeva #PatientData #PrescriberData #Innovate

"It's a big time commitment. We have to have people on the team that will go in there regularly and look at that. They're spending multiple hours a month sorting through all of this data." - Sanofi Field Medical Director Dave Harper on #Insights Does this sound familiar? For many #MedicalAffairs teams, the sheer volume of data can be overwhelming. Sorting through insights, categorizing them, and identifying key issues takes time—time that could be spent on more strategic tasks. At Kwello, we're here to help. Our Accelerated Insights Program transforms how you gather, analyze, and leverage insights. We reduce the time from insight to impact, ensuring that your insights are not just read but acted upon. 👉 With Kwello, you can streamline your processes, focus on what matters most, and drive real results. Learn more: https://lnkd.in/ebDudZrz

Registration is NOW OPEN for the Fierce New Product Planning Summit 2024! Don't miss out on our best deal yet – save $200 off Early Bird Rates for a limited time only by registering now with code SUPER! 💸 🔗 Save Your Spot: https://lnkd.in/ez4x-bnM Sneak Peek at This Year's Agenda: 👉Maximize Market Impact: Enhance commercial success by optimizing the pipeline and making prioritization decisions that propel your business forward. 👉Forecasting Mastery: Drive value by analyzing the market and competitive intelligence to create an accurate forecast that keeps you ahead of the curve. 👉Synergize for Success: Effectively drive collaboration between R&D, clinical, and commercial teams to develop an appropriate timeline and practical approach to bringing new products to launch with precision. 👉Brand Messaging Brilliance: Create a compelling brand message to drive your go-to-market strategy and adapt swiftly to match ever-changing market demand, ensuring your brand resonates and endures. 👉Unparalleled Networking with co-located Fierce Biotech Summit: Enjoy the unique opportunity to network with industry leaders during combined meals, breaks, and receptions, and gain exclusive access to the prestigious Fierce Biotech Fierce 15 awards ceremony. Join the Biotech elites and network with this year's winners. Bringing a group? Save up to an extra 25% for groups of three or more! Contact us today for special group rates. 📞 Contact Us: https://lnkd.in/eChvviaZ #FierceNPP #WeAreFierce #FiercePharma #FierceLifeSciences #NetworkingOpportunity #ProductPlanning #SuperEarlyBirdDiscount #innovation #PharmaLeaders #BiotechLeaders #ProductLaunchSuccess #CommercialExcellence #PipelineOptimization #BiotechInnovators #PharmaInnovators #CommercialStrategy

From the point of view of intangible assets, Key Alliance Capital is one of the pillars of the value of Intellectual Capital 🙌🔝🍀 It is very important to work to strengthen it every day🙌

Looking forward to Eryn Veronesi Atypical Digital Life Sciences, and Magnolia talk about Biopharma in the digital era today at 1 pm ET! Learn about the latest trends and insights in the industry. #biopharma #digital

"Digital and in-person interactions should be personalized to truly meet the needs of the individual." - Chase Feiger, M.D. on redefining pharma marketing 🎙️: Listen to Chase speak on the need for personalized engagement on the Modern Clinician webinar from last week, hosted by RoseRx

Let’s continue to explore the 3 best practices for #MSLs with number 2 today. Once you match up business objectives to the right thought leader relationships, it’s time to turn your attention to freshening up #KOL lists in each relevant therapeutic area. It’s critical for #MedicalAffairs teams to update their experts in each therapeutic area to maintain a diversity of perspectives and inject fresh ideas and insights and more often, if possible, with the right data partner where data updates can come as often as real-time or daily. Refreshing the expert list can identify potential rising stars that weren’t initially part of an organization’s core list, illuminate shifts in research focus, and create new collaborations opportunities. Learn more here: https://hubs.la/Q02r5zQ_0

New approaches, fresh thinking, creativity and stepping outside our comfort zones - wholeheartedly embraced by our Human Pharma Leaders last week, as we spent some time offsite focusing on business transformation and our path to 2035. I recognise that the pace of change has never been so great, so at Boehringer Ingelheim we’re not standing still. The needs of patients and healthcare systems continues to intensify and become ever more complex. We’re focused on our transformational journey to meet those challenges. But we also know how to have fun along the way! #LifeForward #BoehringerIngelheim #OurPathTo2035